newsletter masthead
December 7, 2018
IACA Awards Majhail Lifetime Achievement Award
The Indo-American Cancer Association (IACA) awarded Cleveland Clinic researcher Navneet Majhail, MD, MS Majhail, Navneet headshot its Lifetime Achievement Award for Outstanding Contributions to Hematology-Oncology. Majhail received the award on Sunday, December 2 in San Diego, CA at the association's annual meeting.

The Case Comprehensive Cancer Center extends its congratulations to Dr. Majhail on this exceptional accomplishment. He is a member of the Case CCC's Hematopoietic and Immune Cancer Biology Program.
Cancer-focused Summer Undergraduate Research Program (CanSUR) Opens for Applications, Seeks Mentors

The Office of Cancer Training and Education in the 
Case Comprehensive Cancer Center (Case CCC) is now accepting applications  for the new Cancer-focused Summer Undergraduate Research Program (CanSUR).   The program offers a unique,  immersive experience that will help prepare highly motivated undergraduates for a career in  cancer research. Applications must be received by February 1, 2019.

If you would like to volunteer to mentor an undergraduate student for the summer with permission from your lab PI, please contact and sign up for the "Train the Mentors" workshop.
Join the Case Comprehensive Cancer Center Team

Case Comprehensive Cancer Center (Case CCC)  Case CCC logois seeking a Director of Research Programs (Senior Research Associate). The role will work closely with the Center Director and Scientific Program leaders, serving as subject matter expert on scientific and technical grant writing for researchers and non-research staff to develop, direct, and manage a variety of programs and funding opportunities in the Center designed to build collaborative research in cancer. more> 

The position provides direct administrative support for the Case CCC's Clinical Research Office (CRO) and works directly with the CRO Medical Director and the Associate Director and Deputy Associate Director for Clinical Research. The person in this position is responsible for coordinating oversight for all clinical research taking place within the Case CCC by engaging all entities conducting patient based research through those hospital and institution based clinical trials units. more>

The program administrator will develop, direct, and manage a variety of training and education programs in the Case CCC and the National Center for Regenerative Medicine (NCRM). They  will be responsible for the fiscal management of the diverse training grant portfolio (federal and foundation) in the Case CCC and NCRM. This person will work closely with the Director of the NCRM, the Assistant Director of Cancer Training and Education in the Case CCC, and other Case CCC administrative members to develop new applications for federally funded training programs, implement overall strategy for developing programs and establish funded graduate programs that will expand the scope of training in cancer and stem cell research. more>
Athymic Shared Resource Fee Change
The Athymic Animal and Preclinical Therapeutics Shared Resource is increasing prices for the following services effective January 1, 2019:
  • NSG (NOD/SCID/IL2Rgamma): $70
  • NCR nu/nu: $50
  • NOD/SCID: $60
  • Cage day care charge: $1.25
Cancer Center Seminar Series: "On prediction in complex systems"
Dec 7, 12p | WRB Auditorium

abazeed-mohamed-md-phd Join us Friday, December 7 at 12p in the WRB Auditorium to hear Mohamed Abazeed, MD, PhD  present "On prediction in complex systems.  This seminar is presented by the GI Cancer Genetics Program. 

As a physician scientist, Dr. Abazeed uses his experiences in patient care to develop a clinically relevant research program to translate laboratory discoveries into potential improvements in clinical care. His group has contributed to our understanding of the variation in the sensitivity of tumors to DNA damaging therapies (chemo-/radio-therapy) and its underlying genetic basis. These and other ongoing efforts in his laboratory are intended to provide a rational basis for preventing therapeutic resistance  in cancer.  more>
3rd Annual Cancer Disparities Symposium
Mar 1, 2019 | Tinkham Veale University Center
Disparities Banner 2019-final
The 3rd Annual Cancer Disparities Symposium will be held Friday, Mar 1, 2019. 


Registration is now OPEN for this symposium.  
Click here for registration information.

2019 Symposium Highlights
  • Eliseo J. Pérez-Stable, MD, Director, National Institute on Minority Health and Health Disparities (NIMHD), National Institutes of Health (NIH), will discuss cancer disparities research trends and funding opportunities. 
  • Rick Kittles, PhD, Associate Director of Health Equities at City of Hope, will give a research-focused presentation on cancer disparities research. 
  • An entire afternoon session is devoted to research aligned with abstract submissions; this includes oral presentations from selected abstracts, plus a poster session. Students who submit an abstract can attend this symposium free of charge. 
  • The audience for this symposium is diverse in background and field, allowing attendees to interact, network, and expand their knowledge and opportunities for collaboration.
Call for Abstracts

The Case Comprehensive Cancer Center invites multidisciplinary researchers, community agencies and organizations to submit abstracts for presentation at the 3rd Annual Cancer Disparities Symposium. Abstracts will be divided into two tracks: Scientific Research and Community Programs. Meritorious abstracts will be selected for oral presentations. 

**Students who submit an abstract are able to register for FREE! Submit your abstract to   BEFORE  registering. You will be emailed a discount code to be entered on the registration form so that you receive the discount. 


Abstracts must be submitted via email ( ) by 5pm EST on December 21, 2018.
Parents - Nov 27, 2018
"Even when her body was battered by infection or the effects of chemo, Grace took the treatments like a champ," said  Seth Rotz, MD, pediatric oncologist at Cleveland Clinic and member, Case CCC.

NY Times - Nov 28, 2018
Cleveland Clinic hematologist and oncologist Mikkael A. Sekeres, MD, MS, member Case CCC, illustrates a clinical experience where he monitored his patient's EMR from 130 miles away as her health deteriorated in real time. "What I really needed was to share the loss of our patient with another human being," he said.

Anant Madabhushi Named IEEE Fellow
CWRU's The Daily - Nov 30, 2018
Anant Madabhushi, MS, PhD was recognized by the Institute of Electrical and Electronics Engineers (IEEE) as an IEEE Fellow. A member of the Case CCC's Cancer Imaging Program, Dr. Madabhushi was honored for contributions in image analysis tools for diagnosis and prognosis of diseases.
NIH BULLETIN - Notices and Funding Opportunities
Notice: Changes to the NIH Academic Research Enhancement Award (AREA)/R15 Program 

Fri, Dec 7
Hem/Onc Grand Rounds
Brenda Cooper, MD
Professor, Medicine; Clinical Director, Adult Hematologic Malignancies Blood and Marrow Transplant Program, UHCMC
Immune checkpoint inhibitors in acute leukemia
8a Wearn 137

Taussig Cancer Institute Grand Rounds
8a CA5-120

Cancer Center Seminar Series
Mohamed Abazeed, MD, PhD
Director, Center for Precision Radiotherapy
Department of Radiation Oncology
Assistant Professor of Medicine, Cleveland Clinic Lerner College of Medicine
"On prediction in complex systems"
12p WRB Auditorium
Mon, Dec 10
Genomic Medicine Institute Trainee Distinguished Speaker
Mien-Chie Hung, PhD
Vice President for Basic Research
Professor and Chair
University of Texas MD Anderson Cancer Center
"Marker-guided target therapy, PARP and EGFR inhibitors, and development of effective checkpoint therapy"
12p NE1-205
Tues, Dec 11
Radiation Oncology Grand Rounds
Javier Torres-Roca, MD
Director of Research,  Associate Professor and Radiation Oncologist, Department of Radiation Oncology, Moffitt Cancer Center
"Precision Medicine in Radiation Oncology"
8:10a Kulas Auditorium

Cancer Impact Lecture
Randal Kimple, MD, PhD
Associate Professor, Human Oncology, University of Wisconsin
1p NE1-205

Cancer Research in Progress Seminar
3p WRB 3-136
Thurs, Dec 13
Developmental Therapeutics Journal Club
9a R4-013

Molecular Biology and Microbiology Seminar
Mary Ann Checkley and Benjamin Luttge
Karn lab, CWRU
1p SOM W203
Fri, Dec 14
Taussig Cancer Institute Grand Rounds
8a CA5-120

PRCHN Seminar
Maritza Salazar Campo, PhD
Assistant Professor, Paul Merage School of Business, University of California at Irvine
"Integrating diversity in interdisciplinary teams: The role of team leaders and team training"
9a BRB 105

Cancer Center Seminar Series Guest Speaker
Eben Rosenthal, MD Associate Director of Clinical Care, Stanford Cancer Institute
Medical Director, Stanford Cancer Center
"Enhanced surgical margin detection - 'Light up my tumor' "
12p WRB Auditorium
Mon, Dec 17
Cancer Center Research Chalk Talk
1p WRB 3-136
Tues, Dec 18
Radiation Oncology Grand Rounds
Mamta Singh, Phd
Physicist IV, Associate Professor, Curricular Affairs, CWRU 
"Health Systems Science 101"
8:10a Lerner Tower B-151

Cancer Impact Lecture
Janna Kiselar, PhD
Assistant Director, Center for Proteomics and Bioinformatics, CWRU
1p NE1-205

Cancer Drug Discovery and Resistance
Clark Distelhorst, MD, PhD
Professor, Hematology and Oncology, CWRU/UH
3p WRB 1-422D
Thurs, Dec 20
Developmental Therapeutics Journal Club
9a R4-013

Molecular Biology and Microbiology Seminar
Marie McCausland and Braulio Llorens
Levine lab, CWRU
1p SOM W203
Fri, Dec 21
Taussig Cancer Institute Grand Rounds
8a CA5-120

Deadline: Open

Deadline: Open

Deadline: Open
Case Comprehensive Cancer Center